Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

2017 NCCN Annual Conference
Tweet this page

Suzanne George, MD, of Dana-Farber Cancer Institute, discusses current and emerging systemic therapies for soft-tissue sarcoma and the options for multimodality treatment.

Advertisement

Advertisement



Advertisement